• AICAR Phosphate: AMPK Assay Workflows

  2026-09-08

  AICAR phosphate, also known as Acadesine, connects AMPK pathway activation with apoptosis-focused workflows in B-CLL and exploratory mitochondrial studies. This guide combines dose-ranging, caspase and cytochrome c readouts, storage guidance, and a carefully bounded extension to mechanically loaded periodontal models.

• HyperScript RT SuperMix for qPCR: Hypoxia-to-qPCR

  2026-09-08

  HyperScript RT SuperMix for qPCR supports reliable cDNA synthesis from structured or scarce RNA. This article translates recent SQOR–ferroptosis findings in hypoxic pancreatic cancer into practical reverse-transcription and qPCR assay decisions.

• Neuroligin 1, D2-MSNs, and Repetitive Behavior

  2026-09-07

  This Advanced Science study identifies striatal D2 receptor-expressing medium spiny neurons as a cell-type-specific driver of excessive self-grooming and digging after Neuroligin 1 loss. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the work connects D2-MSN hyperactivity with PKC overactivation and provides a mechanistic framework for studying restricted and repetitive behaviors.

• Tomivosertib and Human DRG Hyperexcitability

  2026-09-07

  The reference study provides direct human evidence that MNK inhibition can rapidly and reversibly suppress spontaneous activity in cultured dorsal root ganglion neurons obtained from patients with radiculopathy. By pairing electrophysiology with eIF4E Ser209 target-engagement data, it connects MNK-eIF4E signaling to ectopic sensory-neuron activity relevant to neuropathic pain.

• Nilotinib (AMN-107): From BCR-ABL to Translation

  2026-09-05

  A mechanistic and translational framework for using Nilotinib (AMN-107) to interrogate BCR-ABL signaling, kinase-driven cancer models, resistance biology, and carefully bounded neurodegeneration hypotheses.

• CUDC-907: Dual PI3K and HDAC Workflow Guide

  2026-09-04

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis. This guide covers preparation, controls, readouts, and troubleshooting; the compound is for scientific research only and not for diagnostic, therapeutic, or clinical use.

• Calcitriol Workflows for VDR Research

  2026-09-04

  Calcitriol enables controlled activation of vitamin D receptor signaling in endometrial, immune, bone, and cancer models. This practical guide connects formulation, time-course design, mechanistic validation, and troubleshooting to help researchers distinguish differentiation, cytokine, and proliferation effects.

• S1P/S1PR3 Drives Neuronal Apoptosis After ICH

  2026-09-03

  The reference study identifies S1PR3 as a mediator of neuronal apoptosis after acute intracerebral hemorrhage and connects receptor activation with CCL2, TNF-α, PI3K/AKT, and caspase-3 signaling. Its mouse and HT22-cell experiments suggest that pharmacological S1PR3 inhibition may reduce secondary neuronal injury, while also defining important limitations for translation beyond the tested models.

• BFH772 (VEGFR2 inhibitor) Workflow Guide

  2026-09-03

  BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of receptor-driven angiogenesis, including endothelial and tumor angiogenesis models. Its water insolubility and defined kinase selectivity make it unsuitable for aqueous stock preparation, broad-spectrum kinase screening, or experiments requiring an established in vivo dosing regimen without additional optimization.

• Cyclopamine: Hedgehog Signaling Inhibitor Workflows

  2026-09-02

  Cyclopamine is a Smoothened-targeting Hedgehog signaling inhibitor for connecting pathway blockade with proliferation, apoptosis, invasion, and developmental phenotypes. This practical guide covers dose design, breast and colorectal cancer workflows, teratogenicity studies in animal models, and troubleshooting strategies that separate on-target biology from formulation or assay artifacts.

• LY2886721: Practical BACE Inhibitor Workflows

  2026-09-02

  Build more informative BACE1 experiments with LY2886721 by pairing amyloid beta reduction with APP-processing and synaptic readouts. This workflow-oriented guide covers solubility control, dose selection, neuronal assay design, translational biomarker use, and troubleshooting.

• Vemurafenib: Designing Better Melanoma Assays

  2026-09-01

  Vemurafenib and PLX4032 provide a precise pharmacological probe for BRAF-mutant melanoma biology. This guide translates multi-omics resistance findings into better assay design, temporal readouts, genotype controls, and research-use workflows.

• Cardiogreen: Imaging and Phototherapy Workflows

  2026-09-01

  Cardiogreen (Indocyanine Green) combines vascular-space fluorescence with near-infrared phototherapy utility, supporting applications from cardiac output measurement to cell-death assays. This workflow-focused guide connects practical handling and troubleshooting with emerging photothermal immunology findings in oral squamous cell carcinoma.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-31

  The reference study links ATRX deficiency in high-grade glioma cells to increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its combination experiments further indicate that pairing these inhibitors with Temozolomide may produce pronounced toxicity in ATRX-deficient models, supporting ATRX status as an important variable in glioma drug-response research.

• GPR35, YAP/TAZ, and Anchorage-Independent CRC Growth

  2026-08-31

  Otkur et al. show that GPR35 supports anchorage-independent growth in colorectal cancer cells through increased YAP/TAZ activity, despite having limited effects on proliferation in conventional two-dimensional culture. The study identifies CID-2745687 as a pharmacological tool that suppresses this phenotype and positions GPR35 antagonism as a way to investigate YAP/TAZ hyperactivation in colorectal cancer.

7712 records 1/515 page Next 12345 下5页 Last page